FDA issued a Warning Letter to CGA Limited on 12/19/2019 as a result of this inspection.
483 CGA May 2019

483 CGA May 2019

$119 - Not in Stock

FDA investigators audited the CGA - Laventille, Trinidad & Tobago facility and issued inspectional observations (via FDA 483) on 31 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 31 May 2019
  • Location: Laventille, Trinidad & Tobago
  • FEI: 3008527957

Pre-Order Not Available